Triple Therapy or Triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents

被引:14
|
作者
Francescone, Steven [1 ]
Halperin, Jonathan L. [1 ]
机构
[1] Mt Sinai Hosp, Med Ctr, Cardiovasc inst, New York, NY 10029 USA
关键词
D O I
10.1016/j.jacc.2007.11.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:826 / 827
页数:2
相关论文
共 50 条
  • [1] Triple antithrombotic therapy for atrial fibrillation and coronary stents
    Shmyr, Danielle
    Van der Merwe, Vanessa
    Yakiwchuk, Erin
    Barry, Arden
    Kosar, Lynette
    CANADIAN FAMILY PHYSICIAN, 2017, 63 (05) : 375 - 381
  • [2] Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents
    Paikin, Jeremy S.
    Wright, Douglas S.
    Crowther, Mark A.
    Mehta, Shamir R.
    Eikelboom, John W.
    CIRCULATION, 2010, 121 (18) : 2067 - 2070
  • [3] Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents
    Paikin, Jeremy S.
    Mehta, Shamir R.
    Eikelboom, John W.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (09) : 487 - 488
  • [5] Antithrombotic therapy: triple therapy or triple threat?
    Mega, Jessica
    Carreras, Edward T.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 547 - 552
  • [6] Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kerneis, Mathieu
    Talib, Usama
    Nafee, Tarek
    Daaboul, Yazan
    Pahlavani, Seyedmandi
    Pitliya, Anmol
    Furgan, M. M.
    Datta, Sudarshana
    Kazmi, Hassan A.
    Younes, Ahmed
    Gibson, C. Michael
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 524 - 530
  • [8] Triple antithrombotic therapy benefits patients treated for atrial fibrillation
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (6): : 299 - 299
  • [9] Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting
    Reed, Grant W.
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2013, 36 (10) : 585 - 594
  • [10] Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents
    Enomoto Y.
    Iijima R.
    Tokue M.
    Ito N.
    Nagashima Y.
    Araki T.
    Yamazaki K.
    Utsunomiya M.
    Hori M.
    Itaya H.
    Shiba M.
    Hara H.
    Nakamura M.
    Sugi K.
    Cardiovascular Intervention and Therapeutics, 2014, 29 (3) : 193 - 199